Total Payments
$1.2M
2024 Payments
$314,534
Companies
14
Transactions
1,120
Payment Breakdown by Category
Other$908,362 (78.4%)
Consulting$137,091 (11.8%)
Travel$84,310 (7.3%)
Food & Beverage$26,750 (2.3%)
Education$2,800 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $729,826 | 225 | 63.0% |
| Consulting Fee | $137,091 | 55 | 11.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $101,936 | 21 | 8.8% |
| Travel and Lodging | $84,310 | 407 | 7.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $76,600 | 22 | 6.6% |
| Food and Beverage | $26,750 | 389 | 2.3% |
| Education | $2,800 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $309,312 | 369 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $240,212 | 235 | $0 (2024) |
| GENZYME CORPORATION | $155,237 | 86 | $0 (2024) |
| Synergy Pharmaceuticals Inc | $130,977 | 153 | $0 (2018) |
| Phathom Pharmaceuticals, Inc. | $94,042 | 104 | $0 (2024) |
| ABBVIE INC. | $72,329 | 45 | $0 (2024) |
| Ardelyx, Inc. | $66,226 | 61 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $53,205 | 36 | $0 (2024) |
| Ironwood Pharmaceuticals, Inc | $23,500 | 20 | $0 (2021) |
| Alnylam Pharmaceuticals Inc. | $11,826 | 5 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $314,534 | 251 | GENZYME CORPORATION ($110,136) |
| 2023 | $150,407 | 127 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($46,942) |
| 2022 | $75,977 | 51 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($48,255) |
| 2021 | $51,885 | 32 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($17,144) |
| 2020 | $35,820 | 27 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($21,512) |
| 2019 | $169,677 | 246 | Allergan Inc. ($106,415) |
| 2018 | $208,796 | 228 | Synergy Pharmaceuticals Inc ($93,651) |
| 2017 | $152,217 | 158 | Allergan Inc. ($101,036) |
All Payment Transactions
1,120 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $5,062.50 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $119.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $121.61 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $129.85 | General |
| Category: Gastroenterology | ||||||
| 12/05/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $129.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $6,750.00 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | ABBVIE INC. | LINZESS (Drug) | Travel and Lodging | In-kind items and services | $47.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $28.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | LINZESS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,025.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $9,009.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,090.00 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Gastroenterology | ||||||
| 11/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Travel and Lodging | In-kind items and services | $268.44 | General |
| Category: Gastroenterology | ||||||
| 11/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $185.92 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Gastroenterology | ||||||
| 11/08/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Travel and Lodging | In-kind items and services | $633.35 | General |
| Category: Gastroenterology | ||||||
| 11/08/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Travel and Lodging | In-kind items and services | $621.07 | General |
| Category: Gastroenterology | ||||||
| 11/08/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Travel and Lodging | In-kind items and services | $263.44 | General |
| Category: Gastroenterology | ||||||
| 11/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $94.76 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/08/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Gastroenterology | ||||||
About Dr. Gregory Sayuk, MD
Dr. Gregory Sayuk, MD is a Gastroenterology healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760494280.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Sayuk, MD has received a total of $1.2M in payments from pharmaceutical and medical device companies, with $314,534 received in 2024. These payments were reported across 1,120 transactions from 14 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($729,826).
Ad
Practice Information
- Specialty Gastroenterology
- Location Saint Louis, MO
- Active Since 08/13/2006
- Last Updated 05/07/2024
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1760494280
Products in Payments
- LINZESS (Drug) $324,975
- DUPIXENT (Biological) $175,999
- Trulance (Drug) $130,977
- XIFAXAN (Drug) $121,492
- TRULANCE (Drug) $118,446
- VOQUEZNA (Drug) $94,042
- IBSRELA (Drug) $63,426
- VIBERZI (Drug) $54,249
- GIVLAARI (Drug) $7,776
- Linzess (Drug) $5,747
- IW-3718 $4,569
- OXLUMO (Drug) $4,050
- MOTEGRITY (Drug) $2,006
- RINVOQ (Biological) $1,725
- Sucraid (Drug) $208.01
- SPYGLASS (Device) $112.22
- Smart Pill (Device) $25.00
- XIFIXAN (Drug) $18.95
- Barrx (Device) $12.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Saint Louis
Dr. David Alpers, Md, MD
Gastroenterology — Payments: $935,398
Gastroenterology $935,398
Dr. Matthew Ciorba, Md, MD
Gastroenterology — Payments: $483,512
Gastroenterology $483,512
Dr. Jeffrey Crippin, Md, MD
Gastroenterology — Payments: $413,620
Gastroenterology $413,620
Dr. Mauricio Lisker Melman, Md, MD
Gastroenterology — Payments: $325,080
Gastroenterology $325,080
Dr. Adrian Di Bisceglie, M.d, M.D
Gastroenterology — Payments: $143,272
Gastroenterology $143,272
Dr. Rajesh Keswani, Md, MD
Gastroenterology — Payments: $132,086
Gastroenterology $132,086